ACell Inc.
6640 Eli Whitney Drive,
21046
Columbia, MD
USA
USA
This company is co-exhibitor of
U.S. Department of Commerce, U.S. Commercial Service
Location
Hall map
Fairground map
Our range of products
Product categories
- 05 Commodities and Consumer Goods
- 05.15 Wound care equipment
- 05.15.07 Wound covering / skin substitutes
Wound covering / skin substitutes
Our products
Product category: Wound covering / skin substitutes
CYTAL® BURN MATRIX
ACell’s wound management products are medical devices that maintain and support a healing environment by facilitating remodeling of site-appropriate, functional tissue. Comprised of naturally-occurring urinary bladder matrix (UBM), they maintain an intact epithelial basement membrane. Cytal® devices are appropriate for acute wounds and chronic wounds.
Cytal® Burn Matrix is intended for the management of wounds including: second-degree burns, partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, skin tears), and draining wounds. The device is intended for one time use.
Cytal® Burn Matrix is intended for the management of wounds including: second-degree burns, partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, skin tears), and draining wounds. The device is intended for one time use.
Product category: Wound covering / skin substitutes
MICROMATRIX®
ACell’s Wound Management Products are medical devices that maintain and support a healing environment by facilitating remodeling of site-appropriate, functional tissue. Comprised of naturally-occurring urinary bladder matrix (UBM), MicroMatrix® maintains an epithelial basement membrane and is appropriate for acute wounds and chronic wounds.
MicroMatrix® is intended for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, skin tears), and draining wounds. The device is intended for one-time use.
MicroMatrix® is intended for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, skin tears), and draining wounds. The device is intended for one-time use.
Product category: Wound covering / skin substitutes
GENTRIX® SURGICAL MATRIX
Indications for Use
Gentrix® Surgical Matrix Thin is intended for implantation to reinforce soft tissue where weakness exists in patients requiring urological, gastroenterological, or plastic & reconstructive surgery. Reinforcement of soft tissue within urological, gastroenterological, and plastic & reconstructive surgery includes, but is not limited to, the following procedures: hernia and body wall repair, colon and rectal prolapse repair, tissue repair, and esophageal repair
Gentrix® Surgical Matrix Thin is intended for implantation to reinforce soft tissue where weakness exists in patients requiring urological, gastroenterological, or plastic & reconstructive surgery. Reinforcement of soft tissue within urological, gastroenterological, and plastic & reconstructive surgery includes, but is not limited to, the following procedures: hernia and body wall repair, colon and rectal prolapse repair, tissue repair, and esophageal repair
About us
Company details
ACell is a leading regenerative medicine company that develops and manufactures products designed to facilitate the body’s ability to repair and remodel tissue. Our company helps patients in a variety of settings heal differently. ACell’s products are gradually incorporated within the patient’s body and replaced with site-appropriate tissue. ACell aspires to be the recognized leader in regenerative extracellular matrix (ECM) technology, offering superior healing options for doctors and patients. We are a dedicated team creating high-quality, innovative solutions that we believe will transform standards of medical care, with the goal of improving the quality of life of every patient for whom our products are used. ACell is committed to becoming and remaining an innovative leader in regenerative medical technology.